Patents Assigned to Anhui Biochem Bio-Pharmaceutical Co., Ltd
  • Patent number: 9266852
    Abstract: Disclosed is a daidzein derivative as represented by formula (I), or pharmaceutically acceptable salt thereof. Compared to the daidzein in the prior art, the daidzein derivative hydrochloride, in particular to the 7-O—N,N-diethyl-aminoacetyl daidzein hydrochloride, prepared by the daidzein derivative of the present invention, has better solubility and effect for treating cardiovascular diseases.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: February 23, 2016
    Assignee: Anhui Biochem Bio-Pharmaceutical Co., Ltd
    Inventors: Jun Bai, Caiyue Shen, Shigao Hu